Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Baxalta now part of Shire
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent obtained from participant and/or legally authorised representative before any study related activities (any procedure related to recording of data according to the protocol).
Participant at any age with haemophilia A prescribed ADYNOVI/ADYNOVATE prophylaxis.
Negative factor VIII (FVIII) inhibitor test at study entry.
Decision to initiate treatment with commercially available ADYNOVI/ADYNOVATE has been made by the participant and/or legally authorised representative and the treating physician before and independently from the decision to include the participant in this study.
You may not be if
Previous participation in this study. Participation is defined as signed informed consent.
Known or suspected hypersensitivity to ADYNOVI/ADYNOVATE or related products.
Mental incapacity, unwillingness or other barriers precluding adequate understanding or cooperation.
Clareo Health | A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A
